An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases

Supportive Care in Cancer

Volumn 20, Issue 12, 2012, Pages 3307-3313

  Zeng, Liang ^a   Chow, Edward ^a   Zhang, Liying ^a   Tseng, Ling Ming ^b   Hou, Ming Feng ^c   Fairchild, Alysa ^d   Vassiliou, Vassilios ^e   Jesus Garcia, Reynaldo ^f   El Din, Mohamed A Alm ^g   Kumar, Aswin ^h   Forges, Fabien ⁱ   Chie, Wei Chu ^j   Bedard, Gillian ^a   Bottomley, Andrew ^k  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CROSS CANCER INSTITUTE   (Canada)

^e Bank of Cyprus Group Oncology Centre   (Cyprus)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g TANTA UNIVERSITY HOSPITAL   (Egypt)

^h REGIONAL CANCER CENTRE   (India)

ⁱ UNIVERSITÉ JEAN MONNET   (France)

^j NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^k EORTC DATA CENTER   (Belgium)

more..

Author keywords

Bone metastases; EORTC QLQ BM22; EORTC QLQ C30; Minimal clinically important difference; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAZIL; CANADA; CYPRUS; DETERIORATION; EGYPT; EMOTION; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER BONE METASTASIS MODULE 22; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CORE MEASURE 30; FINANCIAL MANAGEMENT; FOLLOW UP; FRANCE; FUNCTIONAL DISEASE; HEALTH STATUS; HUMAN; INDIA; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SAMPLE SIZE; SCORING SYSTEM; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; FATIGUE; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84868505660     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1484-x     Document Type: Article

References (22)

1. Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Canc 8(3):175-179
2. Jacobsen PB, Weitzner MA (1999) Evaluation of palliative endpoints in oncology clinical trials. Cancer Control 6(5):471-477
3. Chow E, Nguyen J, Zhang L et al (2012) International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer 118(5):1457-1465
4. Crosby RD, Kolotkin RL, Williams GR (2003) Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 56(5):395-407
5. Samsa G, Edelman D, Rothman ML et al (1999) Determining clinically important differences in health status measures: a general approach with illustration to the health utilities index mark II. PharmacoEconomics 15(2):141-155
6. Eton DT, Cella D, Yost KJ et al (2004) A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 57(9):898-910
7. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582-592
8. Cella D, Eton DT, Lai JS et al (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales. J Pain Symptom Manag 24 (6):547-561
9. Maringwa J, Quinten C, King M et al (2011) Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol 22 (9):2107-2112
10. Maringwa JT, Quinten C, King M et al (2011) Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer 19(11):1753-1760
11. Chow E, Hird A, Velikova G et al (2009) The european organisation for research and treatment of cancer quality of life questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer 45(7):1146-1152
12. Chow E, Hoskin P, Mitera G et al (2011) Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82 (5):1730-1737
13. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376
14. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 scoring manual (3rd edition). European Organisation for Research and Treatment of Cancer, Brusselss
15. Revicki D, Hays RD, Cella D et al (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61(2):102-109
16. Scott NW, Fayers PM, Aaronson NK, et al. (2008) EORTC QLQC30 reference values. EuropeanOrganisation for Research and Treatment of Cancer, Brussels. http://groups.eortc.be/qol/downloads/reference-values-manual2008.pdf
17. Ringash J, Bezjak A, O'Sullivan B et al (2004) Interpreting differences in quality of life: the FACT-H&N in laryngeal cancer patients. Qual Life Res 13(4):725-733
18. Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139-144
19. Ringash J, O'Sullivan B, Bezjak A et al (2007) Interpreting clinically significant changes in patient-reported outcomes. Cancer 110(1):196-202
20. Cella D, Hahn EA, Dineen K (2002) Meaningful change in cancerspecific quality of life scores: differences between improvement and worsening. Qual Life Res 11(3):207-221
21. King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5(6):555-567
22. Lydick E, Epstein RS (1993) Interpretation of quality of life changes. Qual Life Res 2(3):221-226